Original Research
Accepted on 29 Jan 2026
Visomitin as a differentiation-inducing therapeutic agent through SYK inhibition in AML
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 29 Jan 2026
in Ecosystem Restoration
Brief Research Report
Accepted on 29 Jan 2026
in Plant Pathogen Interactions
Review
Accepted on 29 Jan 2026
in Inflammation Pharmacology
Original Research
Accepted on 29 Jan 2026
in Teacher Education
Data Report
Accepted on 29 Jan 2026
in Atmosphere and Climate
Original Research
Accepted on 29 Jan 2026
in Obstetrics and Gynecology
Original Research
Accepted on 29 Jan 2026
in Environmental Policy and Governance
Original Research
Accepted on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 29 Jan 2026
in Ophthalmology
Original Research
Accepted on 29 Jan 2026
in Psychology in Education
Original Research
Accepted on 29 Jan 2026
in Clinical Infectious Diseases
Review
Accepted on 29 Jan 2026
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 29 Jan 2026
in Gastrointestinal Cancers: Colorectal Cancer
Original Research
Accepted on 29 Jan 2026
in Mechatronics
Original Research
Accepted on 29 Jan 2026
in Machine Learning and Artificial Intelligence